The role of the liver X receptor in chronic obstructive pulmonary disease

Andrew Higham, Simon Lea, Jonathan Plumb, Barbara Maschera, Karen Simpson, David Ray, Dave Singh

Research output: Contribution to journalArticlepeer-review

Abstract

Background: There is a need for novel anti-inflammatory therapies to treat COPD. The liver X receptor (LXR) is a nuclear hormone receptor with anti-inflammatory properties.Methods: We investigated LXR gene and protein expression levels in alveolar macrophages and whole lung tissue from COPD patients and controls, the effect of LXR activation on the suppression of inflammatory mediators from LPS stimulated COPD alveolar macrophages, and the effect of LXR activation on the induction of genes associated with alternative macrophage polarisation.Results: The levels of LXR mRNA were significantly increased in whole lung tissue extracts in COPD patients and smokers compared to non-smokers. The expression of LXR protein was significantly increased in small airway epithelium and alveolar epithelium in COPD patients compared to controls. No differences in LXR mRNA and protein levels were observed in alveolar macrophages between patient groups. The LXR agonist GW3965 significantly induced the expression of the LXR dependent genes ABCA1 and ABCG1 in alveolar macrophage cultures. In LPS stimulated alveolar macrophages, GW3965 suppressed the production of CXCL10 and CCL5, whilst stimulating IL-10 production.Conclusions: GW3965 did not significantly suppress the production of TNFα, IL-1β, or CXCL8. Our major finding is that LXR activation has anti-inflammatory effects on CXC10, CCL5 and IL-10 production from alveolar macrophages. © 2013 Higham et al.; licensee BioMed Central Ltd.
Original languageEnglish
Article number106
JournalRespiratory research
Volume14
Issue number1
DOIs
Publication statusPublished - 12 Oct 2013

Keywords

  • Alveolar macrophage
  • COPD
  • Inflammatory cytokines
  • Liver X receptor

Fingerprint

Dive into the research topics of 'The role of the liver X receptor in chronic obstructive pulmonary disease'. Together they form a unique fingerprint.

Cite this